What Medications Effectively Treat Cough in Children with Bronchitis?

Acute bronchitis in children is typically a self-limiting viral infection of the lower respiratory tract, characterized by cough—often persistent for 2–3 weeks—and sometimes accompanied by low-grade fever, rhinorrhea, or mild wheezing. Antibiotics are not indicated in the vast majority of cases, as bacterial pathogens are rarely responsible; prescribing them unnecessarily contributes to antimicrobial resistance and offers no clinical benefit.

Management focuses on supportive care. Hydration, rest, and environmental measures—such as using a cool-mist humidifier and avoiding irritants like tobacco smoke—are foundational. For symptomatic relief, honey (for children aged 1 year and older) has robust evidence supporting its efficacy in reducing cough frequency and severity, outperforming placebo and some over-the-counter cough suppressants in randomized trials.

Over-the-counter (OTC) cough and cold medications—including dextromethorphan, antihistamines, and decongestants—are not recommended for children under 6 years due to lack of proven efficacy and documented safety concerns, including sedation, paradoxical agitation, and rare but serious adverse events. The U.S. Food and Drug Administration (FDA) and the American Academy of Pediatrics (AAP) explicitly advise against their use in this age group.

In select cases—such as children with underlying reactive airway disease or significant wheezing—inhaled short-acting beta-agonists (e.g., albuterol) may be trialed under medical supervision. However, routine bronchodilator use is not supported by evidence for typical viral bronchitis without objective signs of bronchospasm.

Parents should seek prompt medical evaluation if the child develops high or prolonged fever, respiratory distress (e.g., tachypnea, nasal flaring, intercostal retractions), cyanosis, lethargy, or failure to thrive—signs that may suggest pneumonia, asthma exacerbation, or another serious condition requiring targeted intervention.